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Prox1 Function Is Required for the Development
of the Murine Lymphatic System
The lymphatic system is a vascular network of thin-
walled capillaries and larger vessels lined by a continu-
ous layer of endothelial cells that drain lymph from the
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tissue spaces of most organs and return it to the venousMemphis, Tennessee 38105
system for recirculation. The lack of specific markers
has made it difficult to document the development of
the lymphatic system. As a consequence, the origin
Summary of the lymphatic vessels is still controversial. Historically,
the most widely accepted view of lymphatic develop-
The lack of specific markers has raised problems in ment is the one originally proposed by Sabin (1902,
documenting the precise manner by which the lym- 1904). On the basis of findings from injection experi-
phatic system develops. Here we report that the ho- ments, Sabin proposed that early in development iso-
meobox gene Prox1 is expressed in a subpopulation lated primitive lymph sacs originate from endothelial
of endothelial cells that by budding and sprouting give budding from the veins. In the junction of the subclavian
rise to the lymphatic system. The initial localization of and anterior cardinal veins, the two jugular lymph
these cells in the veins and their subsequent budding sacs develop by endothelial budding from the anterior
are both polarized, suggesting that unidentified guid- cardinal veins (Sabin, 1902, 1904). Later in development,
ance signals regulate this process. In Prox1 null mice, the rest of the lymph sacs originate from the mesoneph-
budding and sprouting is arrested, although vasculo- ric vein and veins in the dorsomedial edge of the Wolffian
bodies. The retroperitoneal lymph sac forms near thegenesis and angiogenesis of the vascular system is
primitive inferior vena cava and mesonephric veins,unaffected. These findings suggest that Prox1 is a spe-
the cisterna chyli forms near the Wolffian bodies, and thecific and required regulator of the development of the
posterior lymph sacs appear near the junctions of thelymphatic system and that the vascular and lymphatic
primitive iliac veins and the posterior cardinal veinssystems develop independently.
(Gray, 1985). Sabin's model proposed that from these
primary lymph sacs the peripheral lymphatic system
then spreads by endothelial sprouting into the sur-
Introduction
rounding tissues and organs where local capillaries form
(Sabin, 1902, 1904; Gray, 1985). However, an alternative
In the early mouse embryo, blood vessels are formed
model has suggested that the initial lymph sacs arise in
from mesodermally derived endothelial cell precursors mesenchyme, independent of the veins, and secondarily
(vasculogenesis). These preexisting vessels grow by en- establish venous connections (Huntington and McClure,
dothelial sprouting and splitting (angiogenesis). Be- 1910).
cause of the identification of a variety of growth factors A recent report of the expression pattern of the vascu-
and receptors involved in these processes (Hanahan, lar endothelial growth factor receptor-3 (VEGFR-3; also
1997; Gale and Yancopoulos, 1999), the molecular known as Flt4) during murine development (Kaipainen
mechanisms that control the development of the vascu- et al., 1995) has provided additional support for Sabin's
lar system are being unraveled. For example, vascular model of lymphatic development. Flt4 is initially ex-
endothelial growth factor (VEGF), the endothelial recep- pressed in angioblasts of murine head mesenchyme,
tor tyrosine kinases Tie1 and Tie2, and Angiopoietin-1 dorsal aorta, cardinal vein, and allantois (Kaipainen et
(Ang1) and Angiopoietin-2 (Ang2) all participate in the al., 1995; Dumont et al., 1998). At embryonic day 12.5
process of vascular development. Results obtained from (E12.5), Flt4 is expressed in developing venous and pre-
loss- and gain-of-function experiments performed with sumptive lymphatic endothelia, and it appears to be-
some of these factors indicated that VEGF-A and its come largely restricted to lymphatic endothelium in
receptors VEGFR-1 and VEGFR-2 are important for en- adult tissues (Kaipainen et al., 1995; Valtola et al., 1999).
dothelial cells' proliferation, migration, and sprouting Overexpression of VEGF-C, a ligand of Flt4, results in
(Risau, 1997; Gale and Yancopoulos, 1999). On the other hyperplasia of lymphatic vessels in transgenic mice
hand, another family of vascular endothelial growth fac- (Jeltsch et al., 1997). Its in vivo application can also
tors (Angiopoietins) and their receptors, Tie1 and Tie2, stimulate angiogenesis in the mouse cornea (Cao et al.,
appear to play a latter role by controlling the sprouting, 1998). These findings suggest that Flt4 may play a role
remodeling, and maturation of the developing vascula- in the development of the vascular and lymphatic system
ture (Gale and Yancopoulos, 1999). By contrast, the (Kukk et al., 1996). Additional analysis of the role of Flt4
mechanisms controlling the development of the lym- in the development of the lymphatic system has been
phatic vascular system are largely unknown, and none hampered by the lack of a viable Flt4 null mouse; inacti-
vation of this gene results in cardiovascular failure andof the mentioned vascular factors are apparently spe-
death of the embryo before the emergence of the lym-cific for lymphatic development.
phatic vessels (Dumont et al., 1998).
The homeobox gene Prox1 was originally cloned by
homology to the Drosophila melanogaster gene pros-* To whom correspondence should be addressed (e-mail: guillermo.
oliver@stjude.org). pero (Oliver et al., 1993). Analysis of the expression
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pattern of Prox1 suggested that it has a functional role in arrow). As development proceeded, the number of
b-gal-positive cells detected anterior to the forelimb re-a variety of tissues, including lens, heart, liver, pancreas,
gion of the embryo increased (Figure 1C). The regional-and central nervous system (CNS) (Oliver et al., 1993).
ization of the b-gal-positive cells in the cardinal veinFunctional inactivation of the Prox1 gene in mice leads
was very obvious at this time (Figure 2C). Remarkably,to embryonic lethality; phenotypic alterations of the lens
the budding and spreading of the cells from the anteriorand liver have so far been identified (Wigle et al., 1999).
cardinal vein was also clearly polarized. As seen in Fig-Here we demonstrate that the Prox1 gene is a specific
ures 1B±1D and 2C (arrow), these budding cells ap-marker of a subpopulation of endothelial cells that by
peared to follow a specific path, moving dorsoanteriorlybudding and sprouting give rise to the murine lymphatic
in the embryo. This observation suggests that somesystem. These findings fully validate Sabin's proposal
as yet unidentified guidance signals may regulate theof the venous origin of the primary lymph sacs (1902,
migration of the Prox1-positive cells.1904). In addition, we also found a striking polarity in
At E12.5, scattered b-gal-positive cells were abundantthe initial localization and subsequent migration of the
and were detected along most of the anteroposteriorlymphatic endothelial cells from the cardinal vein, sug-
axis of the embryo (Figure 1D). The initial localization ofgesting that some guidance mechanism is involved in
the Prox1-expressing cells in the embryonic veins duringthis process. Analysis of nullizygous Prox1 embryos
these early developmental stages suggested that theyshowed that early in development the initial budding of
might correspond to endothelial cells. To confirm theirthe endothelial cells that will give rise to the lymphatic
endothelial character, antibodies specific for the plateletsystem appeared to be unaffected. Later, endothelial
endothelial cell adhesion molecule (PECAM), the vascu-budding and sprouting were completely blocked, caus-
lar endothelial cadherin (VE-cadherin), and b-gal wereing the arrest of lymphatic system development. How-
used in double-labeling immunohistochemistry (Figureever, vasculogenesis and angiogenesis of the vascular
3). Many PECAM-positive cells were present in the em-system was unaffected by Prox1 loss. These results
bryo at this stage (Figures 3A and 4D), reflecting thedemonstrate that Prox1 activity is essential for the nor-
development of the vascular system. However, doublemal development of the lymphatic system and that angio-
labeling with the b-gal antibody was restricted to onlygenesis of the vascular system and development of the
a few of the PECAM-positive cells found in the wall oflymphatic system are independent processes.
the cardinal vein or budding out from the vein (Figure
3A). The endothelial origin of these cells was furtherResults
validated by a similar colocalization of the anti-VE-cad-
herin and anti-Prox1/b-gal antibodies (Figures 3B andProx1 Is a Marker of a Specific Subpopulation
6E). The endothelial character of the Prox1-expressingof Endothelial Cells that Give Rise to the
cells found during earlier developmental stages (E9.5±Murine Lymphatic System
10.5) was also demonstrated by the use of the sameThe Prox1 gene was inactivated in mice by an in-frame
antibodies (Figures 2B, 6A, and 6C). As mentionedinsertion of the b-galactosidase (lacZ) gene (Wigle et
above, as development proceeded, the number of b-gal-
al., 1999). This insertion allowed us to use b-galactosi-
positive cells found scattered along the embryonic axis
dase (b-gal) detection to precisely follow Prox1 expres-
increased (Figures 1C, 1D, and 2C). It could be argued
sion throughout development. Surviving heterozygous
that this increase is a consequence of an independent
Prox1 embryos appeared normal (see Wigle et al., 1999), induction of Prox1-positive cells in the adjacent mesen-
and the distribution of b-gal expression agreed with that chymal cells. However, our results favor the idea that
observed with the use of a specific anti-Prox1 antibody this increase reflected an augmentation in the number
(data not shown). In all but one of the tested genetic of cells budding from the cardinal vein (Figures 2B, 2C,
backgrounds (Wigle et al., 1999), Prox11/2 mice died and 3B). All Prox1-positive cells found near the cardinal
within 2 to 3 days after birth. In contrast to the intestines vein during these early stages of lymphatic development
of their wild-type littermates, the intestines of the hetero- were always double labeled with PECAM and VE-cad-
zygous pups were completely filled with a milky white herin antibodies, as expected for cells of endothelial
fluid a few hours before death (data not shown). This origin.
fluid was probably chyle, the white fluid transported by These results, and the finding that Prox1(b-gal) ex-
the lymphatic vessels of the small intestine (Gray, 1985). pression was only found in a restricted subpopulation
This phenotype suggests a haploinsufficiency effect of of endothelial cells, suggested that they may corre-
Prox1 during the normal development of the enteric lym- spond to those cells that, according to Sabin's model
phatic system. (1902, 1904), give rise to the lymphatic vasculature after
Starting as early as E9.5, a few scattered cells ex- budding from the veins. To further validate this proposal
pressing Prox1 (made visible by X-gal staining) were and to circumvent the lack of early lymphatic-specific
detected in the region anterior to the developing fore- markers, we made use of another combination of anti-
limb of the mouse embryo (Figure 1A). These cells were bodies. Unlike vascular tissue, lymphatic capillaries and
more obvious and abundant at E10.5 (Figure 1B), and lymphatic vessels lack any distinct continuous basal
examination of transverse sections (Figures 2A and 2B) membrane (Fraley and Weiss, 1961; Leak and Burke,
clearly showed the presence of Prox1-positive cells in 1968; Ezaki et al., 1990). Because of this feature, anti-
the wall of the anterior cardinal vein. Interestingly, these bodies recognizing collagen IV and laminin (basal mem-
cells mostly lined only one of the margins of the anterior brane markers) can discriminate between the strongly
cardinal vein. Cell budding from the anterior cardinal labeled vascular system and a weak, or nonexpress-
ing, lymphatic system (Ezaki et al., 1990; Nerlich andvein began to be detected at this stage (Figure 2B,
Prox1 in Lymphatic System Development
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Figure 1. Development of the Lymphatic
System during Mouse Embryogenesis
(A) Starting at E9.5, Prox1 expression (de-
tected here with X-gal staining) was observed
in the region anterior to the developing fore-
limb of the mouse embryo in a restricted sub-
population of endothelial cells (arrow) that will
give rise to the jugular lymph sacs.
(B and C) As development proceeded, endo-
thelial cells began to bud from the anterior
cardinal vein; this development was reflected
at E10.5 and E11.5 by an increase in the num-
ber of b-gal-positive endothelial cells (arrow).
(D) At E12.5, an increased number of endo-
thelial cells were scattered along the antero-
posterior axis of the mouse embryo. This find-
ing probably indicates that additional lymph
sacs (retroperitoneal, posterior) were starting
to develop.
(E) Sprouting of the lymphatic vessels of the
dermis of the skin was detected at E14.5. The
jugular and retroperitoneal (partially covered
by strong b-gal staining in the liver) lymph
sacs were clearly visible (arrowheads).
(F) At E15.5, a fine capillary plexus had super-
ficially developed in the dermis of the whole
embryo. Larger lymphatic vessels were ob-
served in the deeper plexus (arrow).
Schleicher, 1991). The use of these antibodies in combi- stage along most of the embryo, including the respira-
tory and digestive organs (Figure 7). Finally, at E15.5,nation with antibodies against the general endothelial
markers (PECAM and VE-cadherin) and b-gal allowed an extensive lymphatic capillary network covering the
dermis of the skin had developed (Figure 1F), intermin-us to discriminate between the lymphatic system and
the vascular system. As expected for the lymphatic vas- gled with the blood capillaries (Figure 2E), along the
whole embryonic body.culature, the PECAM and b-gal double-labeled cells
(Figure 3A) did not coexpress significant amounts of These results demonstrate that Prox1 is a specific
marker of a subpopulation of endothelial cells exclu-collagen IV (Figure 3C, arrow) or laminin (Figure 3D,
arrow). Instead, the PECAM-positive and b-gal-negative sively involved in the development of the murine embry-
onic lymphatic system.cells detected in Figure 3A coexpressed high levels of
collagen IV (Figure 3C, arrowhead) and laminin (Figure
3D, arrowhead), indicating that these cells correspond Budding and Sprouting of Lymphatic Endothelial
Cells Requires Prox1 Functionto vascular tissue. These results indicate that Prox1 is
indeed a marker of a restricted subpopulation of endo- An analysis of Prox1±F1 intercrosses revealed that both
Prox11/2 and Prox12/2 embryos began to develop se-thelial cells that, after budding from the cardinal vein,
will give rise to the jugular lymph sacs. From these sacs, vere edema at about midgestation (E14.5; Figure 4A).
Mouse embryos homozygous for the disrupted Prox1capillary plexuses spread to the neck, head, forelimbs,
and thorax (Gray, 1985). Furthermore, the widespread allele died between E14.5 and E15.0, probably from a
combination of phenotypic alterations (only the lym-expression of b-gal-positive cells observed at E12.5
probably reflects the formation of the additional poste- phatic phenotype is reported here), which may include at
least those already identified for the liver and lymphaticrior lymph sacs (see Figure 1E), which had also been
proposed to develop by endothelial budding from other system. X-gal staining showed the presence of a normal
superficial lymphatic capillary network in the bodies ofveins (Sabin, 1902, 1904; Gray, 1985). At this stage, b-gal-
positive endothelial cells were also detected around Prox11/2 embryos at E14.5 (Figure 4B) and its complete
absence in their homozygous littermates (Figure 4C).the trachea, the esophagus, lung buds (Figure 2C, ar-
rowhead), posterior cardinal vein, and other veins along Nevertheless, development of blood arteries and capil-
laries appeared unaffected in Prox12/2 mice (Figure 4C,the body (data not shown). At E14.5, X-gal staining was
clearly observed in the jugular and perimesonephric re- arrow). The normal development of the vascular system
in E12.5 Prox12/2 embryos was highlighted by whole-gions (Figure 1E). From these sites of lymphatic vessel
development, the sacs formed new sprouts of endothe- mount anti-PECAM immunostaining (Figure 4D) and by
the normal distribution along the body of ink injectedlial cells that started to grow toward the periphery of the
embryo (Figure 1E) and began to enter into the different into the heart of E14.5 Prox12/2 embryos (data not
shown). The normal pumping of the ink into the vascula-organs, forming the local capillaries (Figure 7). At this
stage, Prox1-expressing (b-gal-positive) cells lining lym- ture of Prox12/2 embryos also demonstrated the lack of
any obvious alteration in the function of the heart. Inphatic vessel networks and unstained blood vessels
containing erythrocytes were identified (Figure 2D). addition, this result ruled out the possibility that the
arrest of lymphatic development observed in the Prox1Lymphatic vessels and capillaries were observed at this
Cell
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mutant mice could have been secondary to a heart mal-
function (Prox1 is also normally expressed in the devel-
oping heart).
A detailed chronologic comparison of Prox11/2 and
Prox12/2 embryos was performed to determine precisely
the time at which the lymphatic phenotype appears.
No obvious differences in the number of b-gal-positive
endothelial cells were observed at E10.5 (Figures 5A,
5B, 6A, and 6C). At E11.5, however, the number of scat-
tered b-gal-positive endothelial cells budding from the
anterior cardinal vein of Prox1 homozygous embryos
(Figures 5D and 5F) began to decrease as compared
with that of their heterozygous littermates (Figures 5C
and 5E). Histologic analysis of sections at the level of the
anterior cardinal vein of E11.5 mutant embryos revealed
that the number of b-gal-positive endothelial cells lining
the lumen of the vein was also reduced (Figure 5F).
Finally, at E12.5, only a few dispersed endothelial cells
were occasionally seen budding from the veins of the
Prox1 homozygous mutants. As a consequence of the
lack of endothelial budding, the lymph sacs, the net-
works of lymphatic vessels, and the superficial lym-
phatic capillaries were not developed in the bodies of
the nullizygous embryos at this stage (Figures 5G and
5H). The lack of lymphatic vasculature in the mutant
embryos was confirmed by using the same antibody
combination that was previously used in the analysis of
the Prox11/2 embryos; the only difference at this stage
was that lymphatic endothelial-specific b-gal expres-
sion was no longer detected in the mutant embryo. Con-
trary to what was observed in the Prox11/2 embryos, in
the Prox12/2 littermates all PECAM-positive cells were
strongly double labeled with collagen IV or laminin anti-
bodies (Figures 3E and 3F). This result confirmed that
blood vasculature development was not affected and
that lymphatic vasculature did not develop in the
Prox12/2 embryos.
To further corroborate the lack of lymphatic vascula-
ture, we also used an anti-Flt4 antibody to perform im-
munostaining of sections of Prox1 mutant embryos. It
has been suggested that during later stages of embry-
onic development, Flt4 expression is decreased in the
blood vessel endothelium but is sustained and becomes
lymphatic specific in adult tissues (Kaipainen et al.,
1995; Valtola et al., 1999). Flt4 immunostaining of E12.5
Prox1 heterozygous embryos (Figure 6F) showed some
restricted areas of strong staining (presumably lym-
phatic endothelial cells), intermingled with more abun-
dant cells exhibiting much weaker immunostaining (pre-
sumably vascular endothelial cells). This assumption
Figure 2. Budding of Lymphatic Endothelial Cells Is Polarized
(A) At E10.0, a few b-gal-expressing endothelial cells lining the wall
of the anterior cardinal vein were detected (arrow). All of these cells
were located toward the outer margin of the vein. (arrow). At this stage, some b-gal-positive cells were also seen near
(B) At E10.5, endothelial cells budding from the anterior cardinal the esophagus and lung buds (arrowhead).
vein were beginning to be detected (arrow). The Prox1-expressing (D) In a transverse section of an E14.5 embryo, lacZ-expressing
cells (green) lined the wall of the cardinal vein (arrowhead); they endothelial cells were observed surrounding the lumen of lymphatic
represented only a subpopulation of endothelial cells, as determined vessels and capillaries that have already developed along the em-
by double labeling with anti-PECAM antibodies (red). The rest of the bryonic body. In the same region, no X-gal staining was seen in
PECAM-positive/Prox1-negative cells corresponded to endothelial the endothelial cells of the blood vessels containing erythrocytes
cells of the vascular system. (arrow).
(C) The polarity in the localization of the endothelial cells in the (E) At E15.5, the lymphatic capillary network of the dermis had
cardinal vein was more obvious at E11.5. The budding of the endo- developed, intermingled with the blood vessels and blood capillar-
thelial cells from the anterior cardinal vein was also clearly polarized. ies. DA, dorsal aorta; CV, cardinal vein; He, heart; SC, spinal cord.
Endothelial cells moved dorsoanteriorly toward the head region Bar, 100 mm.
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Figure 3. Prox1 Expression Is Restricted to Lymphatic Endothelial Cells
The endothelial origin of the b-gal-expressing cells was further corroborated in transverse sections of E12.5 (A) and E11.5 (B) Prox1 heterozygous
embryos double labeled with anti-PECAM (red) and anti-VE-cadherin (purple) antibodies, respectively. Double-labeled cells (arrows) were
detected in the wall of the vein and budding from the vein. The rest of the PECAM- or VE-cadherin-positive cells corresponded to the
endothelial cells of the vascular system. The lymphatic nature of the b-gal-expressing cells was corroborated by the use of antibodies against
the basal membrane markers collagen IV (C) and laminin (D) in adjacent sections of E12.5 Prox11/2 embryos. Lymphatic endothelial cells were
PECAM positive and weakly double labeled with anti-collagen IV and anti-laminin antibodies (arrows). In contrast, the vascular endothelial
cells were strongly double labeled with anti-PECAM and anti-collagen IV or anti-laminin antibodies (arrowheads). Similar immunostaining
criteria were applied to determine whether the lymphatic vasculature was missing in Prox1 homozygous embryos. No endothelial cells weakly
double labeled with PECAM and collagen IV (E) or PECAM and laminin (F) antibodies were found in sections of Prox1 homozygous littermates.
The remaining strongly double-labeled endothelial cells corresponded to those of the vascular system. Bar, 50 mm.
was validated by the comparison of the results of Flt4 lymphatic vasculature development. Except for some
occasional, stronger staining detected in the most distal(Figure 6F) and Prox1 (Figure 6E) immunostainings in
adjacent sections. In the E12.5 Prox1 homozygous lit- regions of the limbs (an area in which Prox1 expression
is not normally detected), no other strong Flt4 stainingtermates, only the weakly stained Flt4-expressing vas-
culature remained (Figure 6H), supporting the concept was observed in E14.5 Prox1 homozygous embryos
(data not shown).that the lack of Prox1 function results in the absence of
Figure 4. Development of the Lymphatic Vasculature Is Arrested in Prox12/2 Mice
(A) At E14.5, most of the heterozygous and all of the homozygous Prox1 embryos developed severe edema (arrow).
(B) At the same stage, normal development of the lymphatic capillary network of the dermis was observed in Prox11/2 embryos. In contrast,
no lymphatic vessels and capillaries were seen in the homozygous littermates (C). Formation of the vascular system seemed to be unaffected
in these mutant mice (arrow).
(D) Normal development of the vascular system in E12.5 Prox12/2 embryos was demonstrated by whole-mount immunohistochemical staining
with an anti-PECAM antibody. Vascular patterning and vascular plexus formation (arrow) appeared to be normal in the mutant mice.
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of Flt4, immunostaining of E10.5 embryos was performed.
No obvious differences in Flt4 expression were found
at this stage between heterozygous and homozygous
Prox1 littermates (Figures 6B and 6D). Similarly, VEGF-C
expression was also found to be apparently unchanged
at E10.5 and E14.5 (data not shown).
Several studies suggested that VE-cadherin plays an
important role in adhesion and angiogenesis (Vittet et
al., 1997; Bach et al., 1998). No obvious differences
that could account for the observed lack of endothelial
budding were detected in the expression of VE-cadherin
in normal and mutant Prox1 embryos at E10.5 and E12.5
(Figures 6A, 6C, 6E, and 6G). Similarly, no obvious differ-
ences in cellular proliferation were found in 5-bromo-
deoxyuridine (BrdU) incorporation assays (Figures 6I
and 6J).
We next addressed whether the observed blockage
in endothelial budding and sprouting affected only the
development of lymphatic vessels and lymphatic capil-
laries located at the level of the dermis of the skin or
whether the development of the entire embryonic lym-
phatic system was also compromised. Dissections of
X-gal-stained E12.5 mutant embryos clearly showed the
absence of lymphatic vessels inside the head (data not
shown). In addition, isolation of the internal organs of
E14.5 mutant embryos demonstrated the complete lack
of lymphatic vessels and capillary plexuses in the Prox1
mutant embryos. In normal E14.5 embryos, lymphatic
vessels consisting of extensive capillary plexuses are
abundant in the respiratory and digestive systems (Gray,
1985). Normally at this stage, the lymphatic vessels and
capillaries of the lungs include a superficial network
beneath the pleura and the deeper vessels that accom-
pany the bronchi, the pulmonary artery and its ramifica-
tions, and the pulmonary vein (Gray, 1985) (Figures 7A
and 7C). b-gal-positive capillaries and vessels clearly
covered the region of the esophagus and trachea of
Prox1 heterozygous embryos (Figure 7A). By contrast,
these same lymphatic structures were totally absent in
the Prox1 nullizygous littermates (Figure 7B). In the lungs
of Prox12/2 mice, the lymphatic vessels of the bronchi
and the superficial capillary network, which appeared
to sprout from the pulmonary vein, were missing (Figures
7B and 7C). The remaining b-gal-positive staining that
was observed in the airway lumen of the mutant lung
(Figures 7B and 7C) did not correspond to lymphatic
Figure 5. Budding and Sprouting of Endothelial Cells Is Arrested in vessels, because these stained cells did not express
Prox12/2 Mice PECAM (data not shown). Instead, they expressed
(A and B) No obvious differences in the number of b-gal-positive Mash1 (immunostaining data not shown), a marker for
endothelial cells were detected in E10.5 Prox11/2 and Prox12/2 lit- neuroendocrine cells in the lungs (Borges et al., 1997).
termates (arrows).
Similarly, in the mutant gut, the lymphatic vessels of(C and D) At E11.5, the number of endothelial cells budding from
the mesenterium and the smaller superficial lymphaticthe anterior cardinal vein began to decrease, as detected by X-gal
vessels and capillaries failed to develop (Figures 7Dstaining (arrows).
(E and F) At E11.5, fewer b-gal-positive endothelial cells were seen and 7E).
lining the wall of the cardinal vein, and a reduced number seemed
to have bud from the vein (arrow).
Discussion(G and H) At E13.5, normal endothelial sprouting was observed in
the dermis of Prox11/2 embryos. In the same region of their Prox12/2
The Prox12/2 embryos are the first mutants in which thelittermates, no lymphatic vessels and capillaries were observed. CV,
cardinal vein. Bar, 100 mm. development of the whole lymphatic vasculature has
been found to be specifically affected, suggesting that
vascular and lymphatic systems develop independently.
The detailed analysis of Prox1 expression in the lym-To determine whether the lack of lymphatic vascula-
ture observed in the Prox1 homozygous embryos could phatic endothelium reported in this paper provides
strong support for the original model proposed by Sabinbe due to an alteration in the normal early expression
Prox1 in Lymphatic System Development
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Figure 6. Prox12/2 Embryos Lack Lymphatic
Vessels
(A and C) No obvious differences in the num-
ber of b-gal-positive endothelial cells (green)
lining the wall of the anterior cardinal vein
were detected in E10.5 Prox11/2 and Prox12/2
littermates. No obvious differences were de-
tected in the expression of VE-cadherin (red)
either. At this stage, no differences were ob-
served in Flt4 expression in vascular and lym-
phatic endothelial cells (green) of adjacent
sections of Prox11/2 (B) and Prox12/2 (D) lit-
termates. Flt4-expressing lymphatic endo-
thelial cells can be identified by comparing
their staining with the corresponding ones of
b-gal shown in (A) and (C). (E) b-gal-positive
endothelial cells labeled in green (arrow) were
seen in the vicinity of the cardinal vein in
E12.5 Prox11/2 embryos, and they were dou-
ble labeled with VE-cadherin antibody (red).
(F) A near adjacent section to (E), showing in
the vicinity of the cardinal vein a subpopula-
tion of cells strongly labeled with anti-Flt4
antibodies (arrow). These strongly-labeled
cells appeared to correspond to those b-gal-
positive cells shown in (E) and thus corre-
spond to lymphatic endothelial cells. Vascu-
lar endothelial cells were weakly stained with
anti-Flt4 (F). No detectable differences in the
expression of VE-cadherin (red) were also
found at E12.5 in Prox11/2 (E) and Prox12/2
(G) embryos. (H) No cells strongly labeled with
anti-Flt4 antibodies were found in E12.5
Prox1 nullizygous embryos, supporting the
concept that lymphatic vasculature develop-
ment has been arrested. Only vascular tissue
weakly stained with anti-Flt4 antibodies was
detected. BrdU incorporation assays de-
tected no obvious differences in cellular pro-
liferation in Prox1 heterozygous (I) and Prox1
homozygous (J) E11.5 littermates. BrdU in-
corporation (green) was observed in some of
the b-gal-expressing cells (red) found in and
budding from the veins of both embryos
(arrows). CV, cardinal vein. Bar, 100 mm.
almost 100 years ago (1902, 1904) that suggested that endothelial sprouting from these primary lymph sacs.
This role of Prox1 seems to be accomplished in a time-primary lymph sacs originate by endothelial cell budding
from the veins. Our results clearly demonstrate that dependent manner and follows the normal time table
for the formation of the lymphatic vasculature in eachProx1 has an important function during the early forma-
tion of the lymph sacs by endothelial venous budding, individual embryonic structure. Supporting this hypoth-
esis is the fact that no obvious difference was initiallyas well as probably later during lymphatic growth by
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Figure 7. Lack of Prox1 Activity Blocks Lym-
phatic Development in the Respiratory and
Digestive Tracts
(A) At E14.5, lymphatic vessels consisting of
extensive capillary plexuses were abundant
in the respiratory and digestive systems of
Prox11/2 embryos. These vessels, which
were composed of lacZ-expressing cells
(arrow), were located around the esophagus,
the trachea, and the pulmonary bronchi.
(B and C) In homozygous littermates, no lym-
phatic vessels were observed in the trachea,
esophagus, and lungs. The lymphatic vessels
found in the normal lungs (arrow in [C]) were
missing in the mutant ones. The remaining
b-gal-expressing cells observed in the mu-
tant lungs (blue staining in [C]) corresponded
to neuroendocrine cells.
(D) In the intestines of E14.5 heterozygous
embryos, lymphatic vessels developed in the
mesenteries (arrow).
(E) X-gal-stained cells were no longer de-
tected in the mesenteries of the homozygous
littermates.
seen in the numbers of b-gal-positive endothelial cells suggested that the budding of the lymphatic endothelial
cells that is still detected in E11.0±11.5 Prox1 mutantin the wall of the veins of heterozygous and mutant
E10.5 Prox1 embryos. It was not until approximately 1 embryos is no longer polarized (J. T. W. and G. O.,
unpublished observations).day later (E11.0±11.5), when extensive budding from the
veins had begun, that the number of budding endothelial In the future, it will be important to determine the
mechanisms by which Prox1 participates in the processcells in the Prox1 mutant embryo was less than that in
the heterozygous littermate. of endothelial budding and sprouting. Matrix proteolysis
and endothelial cell migration are important angiogenicLymphatic vasculature of the thorax and abdominal
viscera have been proposed to arise by endothelial steps that are known to be regulated by different metal-
loproteinases (Hiraoka et al., 1998). It is thus temptingspreading from the lymph sacs (Sabin, 1902, 1904; Gray,
1985). This proposal is supported by our finding that the to speculate that Prox1 may specifically regulate the
expression of some cell adhesion molecules or metallo-arrest in the budding of endothelial cells from the veins
of Prox1 mutant embryos, which as early as E12.5 re- proteinases required for budding and sprouting of the
lymphatic endothelial cells. Alternatively, Prox1 maysulted in the lack of formation of lymph sacs, led to the
arrest in the development of lymphatic capillary plex- regulate the expression of some guidance signals re-
quired for maintenance of the budding and migration ofuses in the respiratory and digestive systems.
Sabin's model of lymph sac formation by endothelial the lymphatic endothelial cells. Prox11/2 and Prox12/2
mice are valuable tools that will help us to understandbudding from the veins suggested that arterial and ve-
nous formation must first take place. An initial step re- the normal development of the lymphatic system and
develop therapies for promoting or inhibiting lymphaticquires the formation of the endothelial cell precursors
that will give rise to the embryonic vascular and lym- development. The generation of conditional Prox1 knock-
outs should also help us to analyze the developmentphatic systems. Specific regulatory gene pathways con-
trol vasculogenesis and angiogenesis during the forma- of the lymphatic system in a time- and tissue-specific
manner.tion of the embryonic vasculature (Suri et al., 1996;
Hanahan, 1997). VEGF-C and its receptor, Flt4, may be Finally, it is interesting that Prox1 was originally cloned
by its homology to the fly prospero gene (Oliver et al.,required for the time-dependent development (prolifera-
tion) of vascular and lymphatic endothelial cells. Starting 1993). The hypothesis that Prox1 may regulate budding
and sprouting of endothelial cells gains additional sup-at around E9.5, the specific expression of an additional
set of genes, such as Prox1 and others yet unknown, port from the fact that prospero is involved in the control
of axonal outgrowth in Drosophila (Vaessin et al., 1991).in a restricted subpopulation of endothelial cells in the
embryonic veins appears to be required to promote
lymphangiogenesis. It is possible that initially all endo- Experimental Procedures
thelial cells in the veins are pluripotent, and it is upon
the expression of genes such as Prox1 that these cells Targeted Disruption of the Prox1 Gene
A b-gal-neomycin resistance cassette was fused in frame to thebecome committed to the lymphatic pathway. Prox1
region encoding the amino-terminal part of Prox1. A 5.1 kb SmaI±expression appeared not to be required to promote the
XhoI fragment containing LacZpA-pGKNeopA sequences was bluntinitial budding from the veins, but instead it may be
ended and ligated to the PflMI-linearized and blunt-ended Prox1
necessary to maintain budding and sprouting of a re- construct (see Wigle et al., 1999). For the purpose of negative selec-
stricted subpopulation of endothelial cells that will give tion, an F9 polyoma early promoter±derived HSV TK gene was added
downstream of the 39 homologous region. R1 embryonic stem cellsrise to the lymphatic system. Recent observations also
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were electroporated and selected according to standard proce- homologue essential for neuroendocrine differentiation in the lung.
Nature 386, 852±855.dures. Positive clones were used to generate chimeras by morula
aggregation. Tail and yolk sac DNA isolation and PCR amplification Cao, Y., Linden, P., Farnebo, J., Cao, R., Eriksson, A., Kumar, V., Qi,
of genomic DNA was performed to identify the mutated allele. J.H., Claesson-Welsh, L., and Alitalo, K. (1998). Vascular endothelial
Heterozygous Prox1 embryos appeared normal, and the distribu- growth factor C induces angiogenesis in vivo. Proc. Natl. Acad. Sci.
tion of b-gal expression agreed with the distribution of Prox1 expres- USA 95, 14389±14394.
sion observed by in situ hybridization analysis. Because 100% of Dumont, D.J., Jussila, L., Taipale, J., Lymboussaki, A., Mustonen,
the newborn heterozygous mice died within approximately 3 days T., Pajusola, K., Breitman, M., and Alitalo, K. (1998). Cardiovascular
after birth, we crossed the original chimeras into four different ge- failure in mouse embryos deficient in VEGF receptor-3. Science 282,
netic backgrounds. Although in three of these backgrounds the 946±949.
mortality rate remained unchanged, the crosses into the NMRI back-
Ezaki, T., Matsuno, K., Fujii, H., Hayashi, N., Miyakawa, K., Ohmori,ground produced 1 in 30 surviving heterozygous newborn mice,
J., and Kotani, M. (1990). A new approach for identification of ratsuggesting that a genetic modifier for the Prox1 gene is present in
lymphatic capillaries using a monoclonal antibody. Arch. Histol. Cy-this strain. From the crosses of these surviving Prox11/2 animals,
tol. 53, 77±86.no newborn Prox12/2 mice were found. Prox12/2 embryos died at
Fraley, E.E., and Weiss, L. (1961). An electron microscopic study ofapproximately E14.5.
the lymphatic vessels in the penile skin of the rat. Am. J. Anat. 109,
85±101.Detection of b-Galactosidase Activity in Embryos and Tissues
To detect b-gal activity, X-gal staining of mouse embryos was per- Gale, N.W., and Yancopoulos, G.D. (1999). Growth factors acting
formed. A postfixation step in 4% paraformaldehyde at 48C was via endothelial cell-specific receptor tyrosine kinases: VEGFs,
done overnight. Vibratome sections were generated as described Angiopoietins, and ephrins in vascular development. Genes Dev.
(Bober et al., 1994). 13, 1055±1066.
Gray, H. (1985). The lymphatic system. In Anatomy of the Human
Immunohistochemistry Body, C.D. Clemente, ed. (Philadelphia: Lea and Febiger), pp.
Immunohistochemical analysis was performed on cryostat sections. 866±932.
Embryos were fixed from 1 hr to overnight in 4% paraformaldehyde,
Hanahan, D. (1997). Signaling vascular morphogenesis and mainte-
cryoprotected with 30% sucrose in phosphate-buffered saline (PBS)
nance. Science 277, 48±50.
overnight, and embedded in tissue freezing medium and sectioned
Hiraoka, N., Allen, E., Apel, I.J., Gyetko, M.R., and Weiss, S.J. (1998).(10 mm). Primary antibodies were the following: rabbit anti-b-gal
Marix metalloproteinases regulate neovascularization by acting as(Cappel, Durham, NC), rat anti-mouse PECAM-1 and rat anti-mouse
pericellular fibrinolysins. Cell 95, 365±377.VE-cadherin (Pharmingen, San Diego, CA), rabbit anti-mouse lami-
Huntington, G.S., and McClure, C.F.W. (1910). The anatomy andnin (Sigma, St. Louis, MO), rabbit anti-mouse collagen IV (Biodesign
development of the jugular lymph sac in the domestic cat (FelisInternational, Kennebunk, ME), and rabbit anti-mouse Flt4 (Santa
domestica). Am. J. Anat. 10, 177±311.Cruz Biotechnology, Santa Cruz, CA). For fluorescence staining, the
following secondary antibodies were used: Alexa 488-conjugated Jeltsch, M., Kaipainen, A., Joukov, V., Meng, X., Lakso, M., Rauvala,
goat anti-rabbit IgG (Molecular Probes, Eugene, OR) and Cy3-conju- H., Swartz, M., Fukumura, D., Jain, R.K., and Alitalo, K. (1997). Hyper-
gated goat anti-rat and anti-rabbit IgG (Jackson ImmunoResearch plasia of lymphatic vessels in VEGF-C transgenic mice. Science 276,
Laboratories). Biotinylated goat anti-rabbit IgG (Jackson Immunore- 1423±1425.
search Laboratories, West Grove, PA) and biotinylated rabbit anti- Kaipainen, A., Korhonen J., Mustonen, T., van Hinsbergh, V.W.M.,
rat IgG (Vector Laboratories, Burlingame, CA) secondary antibodies Fang, G.-H., Dumont, D., Breitman, M., and Alitalo, K. (1995). Expres-
were used in horseradish peroxidase stainings with the Vectastain sion of the fms-like tyrosine kinase 4 becomes restricted to lym-
kit (Vector Laboratories). Anti-PECAM-1 immunostaining of whole- phatic endothelium during development. Proc. Natl. Acad. Sci. USA
mount embryos was done as previously described (Ma et al., 1998). 92, 3566±3570.
BrdU labeling of embryos was performed as described (Wigle et al.,
Kukk, E., Lymboussaki, A., Taira, S., Kaipainen, A., Jeltsch, M., Jou-1999) by using a mouse anti-BrdU monoclonal antibody (Becton-
kov, V., and Alitalo, K. (1996). VEGF-C receptor binding and patternDickinson, San Jose, CA).
of expression with VEGFR-3 suggests a role in lymphatic vascular
development. Development 122, 3829±3837.
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